Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sandhaus

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
Journal of Psychosomatic Research|April 20, 2013
The prospective association of perceived criticism with dyspnea in chronic lung diseaseKristen E Holm, Frederick S Wamboldt, Dee W Ford, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 7, 2023
Quality of Life and Mortality Outcomes for Augmentation Naïve and Augmented Patients with Severe Alpha-1 Antitrypsin DeficiencyPaul R Ellis, Kristen E Holm, Radmila Choate, et al.
International Journal of Behavioral Medicine|July 11, 2014
The social environment and illness uncertainty in chronic obstructive pulmonary diseaseKarin F Hoth, Frederick S Wamboldt, Dee W Ford, et al.
Chest|October 10, 2008
alpha1-Antitrypsin augmentation therapy for PI*MZ heterozygotes: a cautionary noteRobert A Sandhaus, Gerard Turino, James Stocks, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|June 1, 2026
Gene Therapy: Knowledge, Attitudes, and Preferences Among Individuals with Alpha-1 Antitrypsin DeficiencyMatthew M Stern, Kimberly E Foil, Charlie Strange, et al.
COPD|April 4, 2013
Differences in adjustment between individuals with alpha-1 antitrypsin deficiency (AATD)-associated COPD and non-AATD COPDKristen E Holm, Soo Borson, Robert A Sandhaus, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|June 19, 2013
Prospective impact of illness uncertainty on outcomes in chronic lung diseaseKarin F Hoth, Frederick S Wamboldt, Matthew Strand, et al.
COPD|October 7, 2017
Bioequivalence of a Liquid Formulation of Alpha<sub>1</sub>-Proteinase Inhibitor Compared with Prolastin®-C (Lyophilized Alpha<sub>1</sub>-PI) in Alpha<sub>1</sub>-Antitrypsin DeficiencyAlan F Barker, Michael A Campos, Mark L Brantly, et al.
The Journal of Clinical Investigation|April 1, 1986
Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastaseL A Smedly, M G Tonnesen, R A Sandhaus, et al.
BMC Clinical Pharmacology|October 6, 2010
Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha₁-antitrypsin deficiency: a randomized studyJames M Stocks, Mark L Brantly, Laurene Wang-Smith, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Journal of Psychosomatic Research|April 20, 2013
The prospective association of perceived criticism with dyspnea in chronic lung diseaseKristen E Holm, Frederick S Wamboldt, Dee W Ford, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 7, 2023
Quality of Life and Mortality Outcomes for Augmentation Naïve and Augmented Patients with Severe Alpha-1 Antitrypsin DeficiencyPaul R Ellis, Kristen E Holm, Radmila Choate, et al.
International Journal of Behavioral Medicine|July 11, 2014
The social environment and illness uncertainty in chronic obstructive pulmonary diseaseKarin F Hoth, Frederick S Wamboldt, Dee W Ford, et al.
Chest|October 10, 2008
alpha1-Antitrypsin augmentation therapy for PI*MZ heterozygotes: a cautionary noteRobert A Sandhaus, Gerard Turino, James Stocks, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|June 1, 2026
Gene Therapy: Knowledge, Attitudes, and Preferences Among Individuals with Alpha-1 Antitrypsin DeficiencyMatthew M Stern, Kimberly E Foil, Charlie Strange, et al.
COPD|April 4, 2013
Differences in adjustment between individuals with alpha-1 antitrypsin deficiency (AATD)-associated COPD and non-AATD COPDKristen E Holm, Soo Borson, Robert A Sandhaus, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|June 19, 2013
Prospective impact of illness uncertainty on outcomes in chronic lung diseaseKarin F Hoth, Frederick S Wamboldt, Matthew Strand, et al.
COPD|October 7, 2017
Bioequivalence of a Liquid Formulation of Alpha<sub>1</sub>-Proteinase Inhibitor Compared with Prolastin®-C (Lyophilized Alpha<sub>1</sub>-PI) in Alpha<sub>1</sub>-Antitrypsin DeficiencyAlan F Barker, Michael A Campos, Mark L Brantly, et al.
The Journal of Clinical Investigation|April 1, 1986
Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastaseL A Smedly, M G Tonnesen, R A Sandhaus, et al.
BMC Clinical Pharmacology|October 6, 2010
Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha₁-antitrypsin deficiency: a randomized studyJames M Stocks, Mark L Brantly, Laurene Wang-Smith, et al.
Pageof 12